Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XLI vs GSK✓SelectedUSD · GSKXLI vs GSK performance historyLatest closeAs of-2.00%11/19
Stock and ETF performance explorer

XLI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+8.5%
GSK return
+5.3%
Excess return
+3.2%
Maximum drawdown
-13.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.0%-1.6%-0.4%-1.8%
7D-4.8%-4.7%-0.1%-4.1%
30D-3.3%-4.7%+1.4%-2.5%
3M-11.1%-8.8%-2.3%-9.5%
6M-3.9%-4.6%+0.7%-3.4%
YTD+4.9%+1.0%+3.9%+3.4%
1Y+8.5%+6.9%+1.7%+3.8%
All+8.5%+5.3%+3.2%+3.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling